ABBREVIATIONS:4-PDS = 4,4′-dithiopyridine; 4-TP = 4-thiopyridone; p50 = partial pressure at half-saturation; SFH = stroma-free Hb; TFF = tangential flow filtration.
MP4, a new nonvasoactive PEG-Hb conjugate
Article first published online: 8 APR 2003
DOI: 10.1046/j.1537-2995.2003.00341.x
Additional Information
How to Cite
Vandegriff, K. D., Malavalli, A., Wooldridge, J., Lohman, J. and Winslow, R. M. (2003), MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion, 43: 509–516. doi: 10.1046/j.1537-2995.2003.00341.x
This work was supported, in part, by Grants R01 HL 64579-04, R43 HL64996-01, and R44 HL62818-03 from the NHLBI, NIH.
Disclaimer: The authors are employees of Sangart, Inc.
Publication History
- Issue published online: 8 APR 2003
- Article first published online: 8 APR 2003
- Received for publication August 1, 2002; revision received October 30, 2002, and accepted November 18, 2002.
- Abstract
- Article
- References
- Cited By
BACKGROUND: Vasoconstriction has been an obstacle to clinical development of Hb-based O2 carriers. It is proposed that this limitation can be overcome by increasing molecular size and oxygen affinity.
STUDY DESIGN AND METHODS: Surface-modified Hb (MP4) was designed, whose properties are consistent with the theory that cell-free Hb engages autoregulatory vasoconstrictive responses to Hb diffusion in the plasma space (“facilitated diffusion”). Human Hb was modified by reaction first with 2-iminothiolane to add sulfhydryl groups and then with monofunctional maleimide- activated 5-kDa PEG.
RESULTS: MP4 was found to have a molecular weight of 90 kDa, a molecular radius increased relative to native Hb (9.3 ± 1.4 vs. 3.2 nm), high oxygen affinity (p50∼ 5-6 mmHg), and a Bohr effect approximately half that of native human Hb (–0.24Δlogp50/ΔpH). At 4.2 g per dL in Ringer's lactate, its viscosity was 2.5 cP, and its oncotic pressure was 50 mmHg. The t50 of 14C-MP4 in rats was approximately 24 hours. No significant elevation in mean arterial pressure was observed.
CONCLUSION: MP4 appears to be free of a pressor effect, a major limitation to the development of a safe and effective RBC substitutes in the past.

1537-2995/asset/olbannerleft.gif?v=1&s=05048e38d3df7bca9b579f6801d4ffb0d1f36a40)
1537-2995/asset/olbannerright.gif?v=1&s=80a40f0b52bfb45a42076cd036b6ddb39ff98029)
